ICD-10

ICD-10 code D68.312

You are here: Home > ICD-10-CM > D50-D89 > D65-D69 > D68 > D68.3 > D68.31

- ICD-10-CM
TABULAR LIST of DISEASES and INJURIES
- D50-D89
Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- D65-D69
Coagulation defects, purpura and other hemorrhagic conditions
- D68
Other coagulation defects
- D68.3
Hemorrhagic disorder due to circulating anticoagulants
- D68.31
Hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors

D68.312

Antiphospholipid antibody with hemorrhagic disorder

ICD-10 code D68.312 for Antiphospholipid antibody with hemorrhagic disorder

Lupus anticoagulant (LAC) with hemorrhagic disorder
Systemic lupus erythematosus [SLE] inhibitor with hemorrhagic disorder
Excludes1: antiphospholipid antibody, finding without diagnosis (R76.0)
antiphospholipid antibody syndrome (D68.61)
antiphospholipid antibody with hypercoagulable state (D68.61)
lupus anticoagulant (LAC) finding without diagnosis (R76.0)
lupus anticoagulant (LAC) with hypercoagulable state (D68.62)
systemic lupus erythematosus [SLE] inhibitor finding without diagnosis
(R76.0)
systemic lupus erythematosus [SLE] inhibitor with hypercoagulable state
(D68.62)
ICD-10
ATC
ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision
ICD-10

ICD-10 is the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD), a medical classification list by the World Health Organization (WHO).

It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases.

ATC

The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.

It is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology (WHOCC).

DDD

The defined daily dose (DDD) is a statistical measure of drug consumption, defined by the World Health Organization (WHO).

It is used to standardize the comparison of drug usage between different drugs or between different health care environments.

Home Contact Us